Log inSign up
AAOIFI No. 21 screening

Is URGN halal?

UroGen Pharma Ltd.

Not halal

UroGen Pharma Ltd. did not pass AAOIFI screening. The failed check is shown below.

Checked: 15 October 2026

Exchange

NASDAQ

Price

34.56

Day

-5.60%

Market cap

$1.81B

Industry

Biotechnology

Sector

Healthcare

What the company does

UroGen Pharma (Israel/US) makes drugs for urinary-tract cancers: Jelmyto (upper-tract cancer) and Zusduri (bladder cancer, approved 2025), chemotherapy delivered as a gel. Money comes from sales of those drugs.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $193.08M ÷ 36-month average market cap $767.99M = 25.1%

    25.1%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $107.97M ÷ 36-month average market cap $767.99M = 14.1%

    14.1%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    Interest income $5.96M ÷ annual revenue $109.79M (2025) = 5.4%

    5.4%

    Fail

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $1.81B.

For information (AAOIFI 3/1 note): cash + receivables are 77.9% of total assets (2026-06-30). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500

Superinvestors

SEC 13F, 2026 Q3. Up to 45 days delayed.

Held by 1 superinvestors · Average reported price: $36.80

All superinvestor portfolios

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyURGN's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →
Is URGN halal? — UroGen Pharma Ltd. AAOIFI screening result — Limitup